Media Briefing on Moderna Vaccine Trial

Henry Ford Health System discussed its role in the Moderna vaccine trial after the drugmaker announced today that early data from its mRNA trial showed its vaccine is 94.5% effective. Henry Ford was the only hospital in Michigan and one of about 90 nationally chosen to participate in the trial. Henry Ford was a key site for enrolling minority volunteers who were hardest hit by COVID-19.

Leading the media briefing are Paul Kilgore, M.D., MPH, a Henry Ford co-principal investigator in the vaccine trial, and Kellie McFarlin, M.D., a Henry Ford general surgeon and a volunteer vaccine participant. They were joined by Melanie Ivarsson, Ph.D., chief development officer for Moderna.